118th Congress · HOUSE BILLBILL

H.R. 1717 — Interagency Patent Coordination and Improvement Act of 2023

“To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.”

Commerce

Introduced Mar 22, 2023

Last action Mar 22, 2023

Pipeline · Bill → Law

Step 1

Introduced

Mar 22, 2023

Step 2

Referred

Mar 22, 2023

Judiciary

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relatin...

Provisions · 4 sectionsIntroduced in House

Timeline · 2 actions

Mar 22, 2023

Introduced in House

Mar 22, 2023

Referred to the House Committee on the Judiciary.